Association of computed tomography screening with lung cancer stage shift and survival in the United States: quasi-experimental study.
Alexandra L PotterAllison L RosensteinMathew V KiangShivani A ShahHenning A GaissertDavid C ChangFlorian J FintelmannChi-Fu Jeffrey YangPublished in: BMJ (Clinical research ed.) (2022)
A recent stage shift toward stage I NSCLC coincides with improved survival and the introduction of lung cancer screening. Non-white patients and those living in areas of greater deprivation had lower rates of stage I disease identified, highlighting the need for efforts to increase access to screening in the US.